Foghorn Therapeutics Inc (FHTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FHTX Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Foghorn Therapeutics Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent87.66
Marketable Securities, Total MA95.97
Cash & Short-term Investments182.00
Other Current Assets1.25
Prepaid Expense And Other Assets Current3.18
Total Current Assets188.06
Other Assets, Noncurrent34.10
Restricted Cash Current1.25
Restricted Cash Noncurrent2.00
Operating Lease Right Of Use Asset30.39
Total Assets222.17
Liabilities
Accounts Payable, Current AC3.32
Other Liabilities, Current61.09
Total Current Liabilities64.40
Total Long-term Debt0.00
Other liabilities, Noncurrent234.17
Operating Lease Liability Current1.86
Contract With Customer Liability Current52.30
Operating Lease Liability Noncurrent40.13
Contract With Customer Liability Noncurrent193.59
Total Liabilities298.58
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock576.06
Retained Earnings / Accumulated Deficit-652.34
Other Equity-0.13
Common Stockholder's Equity-76.41
Total Stockholder's Equity-76.41
Liabilities & Stockholder's Equity222.17
4 historic quarters locked

Sign in to unlock the full Foghorn Therapeutics Inc balance sheet history.

About Foghorn Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-053819

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.